"GCNT1" Related Products

Expand

Recombinant Human GCNT1, His-tagged

Cat.No.: GCNT1-714H
Product Overview: Recombinant Human GCNT1 (Accession # NP_001481) Arg33-His428, fused with an N-terminal CD33 signal sequence and a C-terminal 6-His tag, was produced in Mouse myeloma cell line, NS0-derived.
Source: NSO cells
Species: Human
Tag: His
Predicted N Terminal: Arg33
Form: Supplied as a 0.2 µm filtered solution in Tris, NaCl and Brij-35.
Bio-activity: Measured by its ability to transfer GlcNAc from UDP-GlcNAc to B1-3 galactosyl-N-acetyl galactosamine.The specific activity is >350 pmol/min/µg, as measured under the described conditions.
Molecular Mass: Recombinant Human GCNT1, His-tagged has a calculated MW of 47 kDa. In SDS-PAGE migrates as 50-57 kDa, reducing conditions.
Purity: >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 µg per lane.
Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
Gene Name: ITGAV integrin, alpha V [ Homo sapiens ]
Official Symbol: ITGAV
Synonyms: ITGAV; integrin, alpha V; antigen identified by monoclonal L230 , integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) , MSK8, vitronectin receptor , VNRA, VTNR; integrin alpha-V; CD51; integrin alphaVbeta3; vitronectin receptor subunit alpha; antigen identified by monoclonal L230; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); MSK8; VNRA; VTNR; DKFZp686A08142;
Gene ID: 3685
mRNA Refseq: NM_001144999
Protein Refseq: NP_001138471
MIM: 193210
UniProt ID: P06756
Chromosome Location: 2q31-q32

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.